ALT 0.00% 0.1¢ analytica limited

setting sales goal, page-12

  1. 6,725 Posts.
    lightbulb Created with Sketch. 14
    Well done for DYOR and in the end that's probably the number one thing to do at this end of the market.

    And I am pretty sure most suffers will not use such a device.
    I thought however the target market was those women whose problem was such that they sort out a clinician. ?
    Where not the original figures touted based on 1% of the 15% who said they would use such a device?

    I cant look it up atm so don't take my word for it.

    Cheers

    Oscar
 
watchlist Created with Sketch. Add ALT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.